List of works - Vanda A Lennon

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

scientific article (publication date: December 2004)

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases

scientific article published on 8 December 2017

Autoimmune Encephalitis Epidemiology and a comparison to Infectious Encephalitis.

scientific article published on 2 January 2018

Autoimmune epilepsy: clinical characteristics and response to immunotherapy

scientific article

Brain abnormalities in neuromyelitis optica

scientific article

Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions

scientific article

Elevated LGI1-IgG CSF index predicts worse neurological outcome.

scientific article published on 2 April 2018

Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.

scientific article published on 19 June 2017

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

scientific article

NMO-IgG: a specific biomarker for neuromyelitis optica

scientific article

Neural autoantibody clusters aid diagnosis of cancer.

scientific article published on 15 May 2014

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

scientific article

P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments.

scientific article published on 20 January 2016

Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond.

scientific article published on 04 February 2015

Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond

scientific article published on 13 June 2011

Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders

scientific article

Striational antibodies in a paraneoplastic context

scientific article published on 05 March 2013

The spectrum of neuromyelitis optica

scientific article

List of works by Vanda A Lennon

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases

Autoimmune Encephalitis Epidemiology and a comparison to Infectious Encephalitis.

Autoimmune epilepsy: clinical characteristics and response to immunotherapy

Brain abnormalities in neuromyelitis optica

Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions

Elevated LGI1-IgG CSF index predicts worse neurological outcome.

Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

NMO-IgG: a specific biomarker for neuromyelitis optica

Neural autoantibody clusters aid diagnosis of cancer.

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments.

Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond.

Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond

Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders

Striational antibodies in a paraneoplastic context

The spectrum of neuromyelitis optica